Company attributes
Other attributes
Indi Molecular is a life science company that is developing a synthetic diagnostic and therapeutic products with antibody-like properties: protein-catalyzed capture agents.
The company started as a spinout from its parent company, Integrated Diagnostics (Indi), with a $1.5 million seed round, led by InterWest Partners together with several angel investors.
Indi Molecular is developing a synthetic protein chemistry platform to revolutionalize targeted therapeutic and molecular imaging. The company has a partnering history that includes the California Institute of Technology, GE Healthcare, the Gates Foundation and the United States Department of Defense.
The company is pursuing a hybrid strategy that emphasizes strategic partnerships focused on oncology therapeutics and molecular imaging, a theranostic approach to therapy. Indi Molecular focuses on high-value and high-need therapeutic indications that include Ovarian Cancer and Pancreatic Cancer.
